+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hypertension Drug"

Familial Primary Pulmonary Hypertension Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Familial Primary Pulmonary Hypertension Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 133 Pages
  • Global
From
Pulmonary Arterial Hypertension (PAH) Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030 - Product Thumbnail Image

Pulmonary Arterial Hypertension (PAH) Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030

  • Report
  • August 2022
  • 115 Pages
  • Global
From
Pulmonary Arterial Hypertension Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Pulmonary Arterial Hypertension Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • January 2024
  • 250 Pages
  • Global
From
Treatment-resistant Hypertension (RHTN) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Treatment-resistant Hypertension (RHTN) - Epidemiology Forecast - 2032

  • Drug Pipelines
  • March 2022
  • 73 Pages
  • Global
From
Treatment-Resistant Hypertension - Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

Treatment-Resistant Hypertension - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • March 2022
  • 146 Pages
  • Global
From
Anti-hypertension - Epidemiology Forecast to 2032 - Product Thumbnail Image

Anti-hypertension - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Dyslipidemia With Hypertension - Epidemiology Forecast - 2032 - Product Thumbnail Image

Dyslipidemia With Hypertension - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Familial Primary Pulmonary Hypertension - Epidemiology Forecast - 2032 - Product Thumbnail Image

Familial Primary Pulmonary Hypertension - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hypertension - Epidemiology Forecast - 2032 - Product Thumbnail Image

Hypertension - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Pulmonary Hypertension - Epidemiology Forecast to 2032 - Product Thumbnail Image

Pulmonary Hypertension - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Chronic Thromboembolic Pulmonary hypertension (CTEPH) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Chronic Thromboembolic Pulmonary hypertension (CTEPH) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Idiopathic Intracranial Hypertension Market Report and Forecast 2023-2031 - Product Thumbnail Image

Idiopathic Intracranial Hypertension Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Cardiovascular Clinical Trials Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Cardiovascular Clinical Trials Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Treprostinil Palmitil Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Treprostinil Palmitil Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Orenitram Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Orenitram Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Treprostinil sodium Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Treprostinil sodium Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
TYVASO Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

TYVASO Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
North America Pulmonary Arterial Hypertension Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Drugs, Type, Route of Administration, and Distribution Channel - Product Thumbnail Image

North America Pulmonary Arterial Hypertension Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Drugs, Type, Route of Administration, and Distribution Channel

  • Report
  • February 2023
  • 143 Pages
  • North America
From
South & Central America Pulmonary Arterial Hypertension Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Drugs, Type, Route of Administration, and Distribution Channel - Product Thumbnail Image

South & Central America Pulmonary Arterial Hypertension Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Drugs, Type, Route of Administration, and Distribution Channel

  • Report
  • February 2023
  • 128 Pages
From
Middle East & Africa Pulmonary Arterial Hypertension Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Drugs, Type, Route of Administration, and Distribution Channel - Product Thumbnail Image

Middle East & Africa Pulmonary Arterial Hypertension Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Drugs, Type, Route of Administration, and Distribution Channel

  • Report
  • February 2023
  • 134 Pages
  • Middle East, Africa
From
Loading Indicator

The Hypertension Drug market is a subset of the Cardiovascular Drugs market, which includes drugs used to treat conditions related to the heart and circulatory system. Hypertension Drugs are used to treat high blood pressure, a condition in which the force of the blood against the artery walls is too high. These drugs work by relaxing the blood vessels, allowing blood to flow more easily and reducing the pressure. Common types of Hypertension Drugs include diuretics, beta-blockers, ACE inhibitors, calcium channel blockers, and angiotensin receptor blockers. Hypertension Drugs are widely used and are an important part of cardiovascular care. They are often prescribed in combination with lifestyle changes such as diet and exercise, and can help reduce the risk of heart attack, stroke, and other cardiovascular diseases. Some companies in the Hypertension Drug market include Pfizer, Novartis, Merck, Sanofi, and AstraZeneca. Show Less Read more